Skip to main content
Top
Published in: Head and Neck Pathology 1/2021

01-03-2021 | Neurofibromatosis Type 1 | Special Issue: Pediatric Pathology

Review of Pediatric Head and Neck Neoplasms that Raise the Possibility of a Cancer Predisposition Syndrome

Authors: Nahir Cortes-Santiago, Kalyani Patel

Published in: Head and Neck Pathology | Issue 1/2021

Login to get access

Abstract

Cancer predisposition syndromes (CPS) are generally heritable conditions that predispose individuals to develop cancer at a higher rate and younger age than their representative general population. They are a significant cause of cancer related morbidity and mortality in the pediatric population. Therefore, recognition of lesions that may be associated with a CPS and alerting the clinicians to its implications is a crucial task for a diagnostic pathologist. In this review we discuss benign pediatric head and neck lesions associated with CPS namely: odontogenic keratocyst, juvenile nasopharyngeal angiofibroma, ossifying fibroma of the jaw, paraganglioma, plexiform neurofibroma, plexiform schwannoma, mucosal neuroma, and nevus sebaceous syndrome; along with malignant tumors such as squamous cell carcinoma. Several head and neck melanocytic, endocrine, and central nervous system tumors can also be associated with CPS; they are beyond the scope of this article. Nasal chondromesenchymal hamartoma is discussed elsewhere in this issue.
Literature
3.
go back to reference Frank SA. Genetic predisposition to cancer - insights from population genetics. Nat Rev Genet. 2004;5(10):764–72.PubMedCrossRef Frank SA. Genetic predisposition to cancer - insights from population genetics. Nat Rev Genet. 2004;5(10):764–72.PubMedCrossRef
5.
go back to reference Ward E, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.PubMedCrossRef Ward E, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.PubMedCrossRef
7.
go back to reference Ripperger T, et al. Childhood cancer predisposition syndromes: a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A. 2017;173(4):1017–37.PubMedCrossRef Ripperger T, et al. Childhood cancer predisposition syndromes: a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A. 2017;173(4):1017–37.PubMedCrossRef
8.
go back to reference Barnes L. Pathology and genetics of head and neck tumors: World Health Organization, International Agency for Research on Cancer. Lyon (France): IARC Press; 2007. Barnes L. Pathology and genetics of head and neck tumors: World Health Organization, International Agency for Research on Cancer. Lyon (France): IARC Press; 2007.
9.
go back to reference Fujii K, Miyashita T. Gorlin syndrome (nevoid basal cell carcinoma syndrome): update and literature review. Pediatr Int. 2014;56(5):667–74.PubMedCrossRef Fujii K, Miyashita T. Gorlin syndrome (nevoid basal cell carcinoma syndrome): update and literature review. Pediatr Int. 2014;56(5):667–74.PubMedCrossRef
10.
go back to reference Giardiello FM, et al. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology. 1993;105(5):1550–2.PubMedCrossRef Giardiello FM, et al. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology. 1993;105(5):1550–2.PubMedCrossRef
12.
go back to reference Guertl B, et al. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol. 2000;31(11):1411–3.PubMedCrossRef Guertl B, et al. Nasopharyngeal angiofibroma: an APC-gene-associated tumor? Hum Pathol. 2000;31(11):1411–3.PubMedCrossRef
13.
go back to reference Klockars T, et al. Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis. Fam Cancer. 2010;9(3):401–3.PubMedCrossRef Klockars T, et al. Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis. Fam Cancer. 2010;9(3):401–3.PubMedCrossRef
14.
go back to reference Schick B, et al. p53 and Her-2/neu in juvenile angiofibromas. Oncol Rep. 2005;13(3):453–7.PubMed Schick B, et al. p53 and Her-2/neu in juvenile angiofibromas. Oncol Rep. 2005;13(3):453–7.PubMed
15.
go back to reference Mishra A, et al. Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend. Am J Otolaryngol. 2016;37(4):317–22.PubMedCrossRef Mishra A, et al. Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend. Am J Otolaryngol. 2016;37(4):317–22.PubMedCrossRef
16.
go back to reference Torresan F, Iacobone M. Clinical features, treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature. Int J Endocrinol. 2019;2019:1761030.PubMedPubMedCentralCrossRef Torresan F, Iacobone M. Clinical features, treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature. Int J Endocrinol. 2019;2019:1761030.PubMedPubMedCentralCrossRef
17.
go back to reference Aldred MJ, et al. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(2):212–8.PubMedCrossRef Aldred MJ, et al. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(2):212–8.PubMedCrossRef
18.
go back to reference Carpten JD, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32(4):676–80.PubMedCrossRef Carpten JD, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32(4):676–80.PubMedCrossRef
19.
go back to reference Waguespack SG, et al. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010;95(5):2023–37.PubMedCrossRef Waguespack SG, et al. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010;95(5):2023–37.PubMedCrossRef
20.
go back to reference Ross JH. Pheochromocytoma: special considerations in children. Urol Clin North Am. 2000;27(3):393–402.PubMedCrossRef Ross JH. Pheochromocytoma: special considerations in children. Urol Clin North Am. 2000;27(3):393–402.PubMedCrossRef
21.
go back to reference Virgone C, et al. Pheochromocytomas and paragangliomas in children: data from the Italian Cooperative Study (TREP). Pediatr Blood Cancer. 2020;67(8):e28332.PubMedCrossRef Virgone C, et al. Pheochromocytomas and paragangliomas in children: data from the Italian Cooperative Study (TREP). Pediatr Blood Cancer. 2020;67(8):e28332.PubMedCrossRef
22.
go back to reference de Tersant, M., et al., Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE). J Endocr Soc, 2020. 4(5): p. bvaa039. de Tersant, M., et al., Pheochromocytoma and Paraganglioma in Children and Adolescents: Experience of the French Society of Pediatric Oncology (SFCE). J Endocr Soc, 2020. 4(5): p. bvaa039.
23.
go back to reference Niemeijer ND, et al. The phenotype of SDHB germline mutation carriers: a nationwide study. Eur J Endocrinol. 2017;177(2):115–25.PubMedCrossRef Niemeijer ND, et al. The phenotype of SDHB germline mutation carriers: a nationwide study. Eur J Endocrinol. 2017;177(2):115–25.PubMedCrossRef
24.
go back to reference Dombi E, et al. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology. 2007;68(9):643–7.PubMedCrossRef Dombi E, et al. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology. 2007;68(9):643–7.PubMedCrossRef
25.
go back to reference Chi, A.C., B.W. Neville, and L. Cheng, Plexiform schwannoma of the oral cavity: report of eight cases and a review of the literature. Head Neck Pathol, 2020. Chi, A.C., B.W. Neville, and L. Cheng, Plexiform schwannoma of the oral cavity: report of eight cases and a review of the literature. Head Neck Pathol, 2020.
26.
27.
go back to reference Rodriguez FJ. Peripheral nerve sheath tumors: the elegant chapter in surgical neuropathology. Acta Neuropathol. 2012;123(3):293–4.PubMedCrossRef Rodriguez FJ. Peripheral nerve sheath tumors: the elegant chapter in surgical neuropathology. Acta Neuropathol. 2012;123(3):293–4.PubMedCrossRef
28.
go back to reference Chaney KE, et al. Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST. Cancer Res. 2020;80(21):4720–30.PubMedCrossRef Chaney KE, et al. Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST. Cancer Res. 2020;80(21):4720–30.PubMedCrossRef
29.
30.
go back to reference Berg JC, et al. Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region. Hum Pathol. 2008;39(5):633–40.PubMedCrossRef Berg JC, et al. Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region. Hum Pathol. 2008;39(5):633–40.PubMedCrossRef
31.
go back to reference Antonescu CR, S.B.a.W.J., Tumors of the peripheral nervous system 4th edition ed. Atlas of tumor pathology (AFIP). 2012: Silver Spring, MD: American Registry of Pathology. Antonescu CR, S.B.a.W.J., Tumors of the peripheral nervous system 4th edition ed. Atlas of tumor pathology (AFIP). 2012: Silver Spring, MD: American Registry of Pathology.
32.
go back to reference Castellanos E, et al. Early genetic diagnosis of neurofibromatosis Type 2 from skin plaque plexiform schwannomas in childhood. JAMA Dermatol. 2018;154(3):341–6.PubMedPubMedCentralCrossRef Castellanos E, et al. Early genetic diagnosis of neurofibromatosis Type 2 from skin plaque plexiform schwannomas in childhood. JAMA Dermatol. 2018;154(3):341–6.PubMedPubMedCentralCrossRef
34.
go back to reference Caltabiano R, et al. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst. 2017;33(6):933–40.PubMedCrossRef Caltabiano R, et al. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst. 2017;33(6):933–40.PubMedCrossRef
35.
go back to reference Owens M, et al. SOS1 frameshift mutations cause pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B. Clin Endocrinol (Oxf). 2016;84(5):715–9.PubMedCrossRef Owens M, et al. SOS1 frameshift mutations cause pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B. Clin Endocrinol (Oxf). 2016;84(5):715–9.PubMedCrossRef
36.
go back to reference Briand, C., et al., Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation. Pediatr Dermatol, 2020. Briand, C., et al., Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation. Pediatr Dermatol, 2020.
37.
38.
go back to reference Mehregan AH, Pinkus H. Life history of organoid nevi: special reference to nevus Sebaceus of Jadassohn. Arch Dermatol. 1965;91:574–88.PubMedCrossRef Mehregan AH, Pinkus H. Life history of organoid nevi: special reference to nevus Sebaceus of Jadassohn. Arch Dermatol. 1965;91:574–88.PubMedCrossRef
39.
go back to reference Solomon LM, Esterly NB. Epidermal and other congenital organoid nevi. Curr Probl Pediatr. 1975;6(1):1–56.PubMed Solomon LM, Esterly NB. Epidermal and other congenital organoid nevi. Curr Probl Pediatr. 1975;6(1):1–56.PubMed
40.
go back to reference Idriss MH, Elston DM. Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases. J Am Acad Dermatol. 2014;70(2):332–7.PubMedCrossRef Idriss MH, Elston DM. Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases. J Am Acad Dermatol. 2014;70(2):332–7.PubMedCrossRef
41.
go back to reference Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):263–8.PubMedCrossRef Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):263–8.PubMedCrossRef
42.
go back to reference Diven DG, et al. Nevus sebaceus associated with major ophthalmologic abnormalities. Arch Dermatol. 1987;123(3):383–6.PubMedCrossRef Diven DG, et al. Nevus sebaceus associated with major ophthalmologic abnormalities. Arch Dermatol. 1987;123(3):383–6.PubMedCrossRef
43.
go back to reference Gurecki PJ, et al. Developmental neural abnormalities and seizures in epidermal nevus syndrome. Dev Med Child Neurol. 1996;38(8):716–23.PubMedCrossRef Gurecki PJ, et al. Developmental neural abnormalities and seizures in epidermal nevus syndrome. Dev Med Child Neurol. 1996;38(8):716–23.PubMedCrossRef
44.
go back to reference Rogers M. Epidermal nevi and the epidermal nevus syndromes: a review of 233 cases. Pediatr Dermatol. 1992;9(4):342–4.PubMedCrossRef Rogers M. Epidermal nevi and the epidermal nevus syndromes: a review of 233 cases. Pediatr Dermatol. 1992;9(4):342–4.PubMedCrossRef
45.
go back to reference Happle, R., The group of epidermal nevus syndromes Part I: Well defined phenotypes. J Am Acad Dermatol, 2010. 63(1): p. 1–22; quiz 23-4. Happle, R., The group of epidermal nevus syndromes Part I: Well defined phenotypes. J Am Acad Dermatol, 2010. 63(1): p. 1–22; quiz 23-4.
46.
go back to reference Kishida ES, et al. Epidermal nevus syndrome associated with adnexal tumors, spitz nevus, and hypophosphatemic vitamin D-resistant rickets. Pediatr Dermatol. 2005;22(1):48–54.PubMedCrossRef Kishida ES, et al. Epidermal nevus syndrome associated with adnexal tumors, spitz nevus, and hypophosphatemic vitamin D-resistant rickets. Pediatr Dermatol. 2005;22(1):48–54.PubMedCrossRef
47.
go back to reference Zutt M, et al. Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets. Dermatology. 2003;207(1):72–6.PubMedCrossRef Zutt M, et al. Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets. Dermatology. 2003;207(1):72–6.PubMedCrossRef
48.
go back to reference Groesser L, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet. 2012;44(7):783–7.PubMedCrossRef Groesser L, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet. 2012;44(7):783–7.PubMedCrossRef
49.
go back to reference Sidell D, et al. Pediatric squamous cell carcinoma: case report and literature review. Laryngoscope. 2009;119(8):1538–41.PubMedCrossRef Sidell D, et al. Pediatric squamous cell carcinoma: case report and literature review. Laryngoscope. 2009;119(8):1538–41.PubMedCrossRef
50.
go back to reference Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people: a comprehensive literature review. Oral Oncol. 2001;37(5):401–18.PubMedCrossRef Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people: a comprehensive literature review. Oral Oncol. 2001;37(5):401–18.PubMedCrossRef
51.
go back to reference Dombrowski ND, et al. Squamous cell carcinoma of the head and neck in children. Int J Pediatr Otorhinolaryngol. 2019;117:131–7.PubMedCrossRef Dombrowski ND, et al. Squamous cell carcinoma of the head and neck in children. Int J Pediatr Otorhinolaryngol. 2019;117:131–7.PubMedCrossRef
Metadata
Title
Review of Pediatric Head and Neck Neoplasms that Raise the Possibility of a Cancer Predisposition Syndrome
Authors
Nahir Cortes-Santiago
Kalyani Patel
Publication date
01-03-2021
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2021
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-021-01292-x

Other articles of this Issue 1/2021

Head and Neck Pathology 1/2021 Go to the issue